The pharmacogenomics market is set to generate record revenue by 2026, fueled by the growing adoption of genomic medicine and personalized treatments. Pharmacogenomics involves the study of how an individual's genetic makeup influences their response to medications, offering personalized insights into drug efficacy and safety. The market's growth is driven by the increasing prevalence of...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian